Urapidil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12661 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 26 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypotrichosis simplex of the scalp | KG + DL |
| 2 | congenital hypotrichosis milia | KG + DL |
| 3 | diffuse alopecia areata | KG + DL |
| 4 | endogenous depression | KG + DL |
| 5 | alopecia | KG + DL |
| 6 | osteoarthritis | KG + DL |
| 7 | pseudoachondroplasia | KG + DL |
| 8 | dysthymic disorder | KG + DL |
| 9 | major depressive disorder | KG + DL |
| 10 | unipolar depression | KG + DL |
| 11 | brachyolmia | KG + DL |
| 12 | Ohdo syndrome and variants | KG + DL |
| 13 | active cochleovestibular Meniere disease | KG + DL |
| 14 | active vestibular Meniere disease | KG + DL |
| 15 | active cochlear Meniere disease | KG + DL |
| 16 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 17 | vertigo, benign recurrent, 2 | KG + DL |
| 18 | osteoarthritis susceptibility | KG + DL |
| 19 | endolymphatic hydrops | KG + DL |
| 20 | myosclerosis | KG + DL |
| 21 | melancholia | KG + DL |
| 22 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 23 | neurotic depression | KG + DL |
| 24 | ligneous conjunctivitis | KG + DL |
| 25 | blepharophimosis - intellectual disability syndrome, Ohdo type | KG + DL |
| 26 | restless legs syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.